Minna Hankaniemi from the Faculty of Medicine and Life Sciences is the only researcher at the University of Tampere to receive funding for a Postdoctoral Research Fellowship. In all, the Research Council on Health of the Academy of Finland granted EUR 4.9 million in fellowship grants to eighteen postdoctoral researchers for the period of 1 September 2017 – 31 August 2020.
Hankaniemi is working to develop vaccines against Coxsackie B (CVB) viruses, which are causing severe morbidity and mortality. Because there are no treatments or vaccines against these diseases, they have a major impact on health care systems worldwide.
The aim of Hankaniemi’s study is to produce Virus-Like Particle (VLP) vaccines against all six CVB virus types. VLP vaccines are safer, more effective and easier to produce than traditional vaccines.